| Price | 0.55p on 27-02-2026 at 19:25:05 |
|---|---|
| Change | 0.05p 9.09% |
| Buy | 0.60p |
| Sell | 0.50p |
| Last Trade: | Buy 1,636.00 at 0.60p |
| Day's Volume: | 1,278,172 |
| Last Close: | 0.60p |
| Open: | 0.575p |
| ISIN: | GB00BYW8QM32 |
| Day's Range | 0.60p - 0.60p |
| 52wk Range: | 0.35p - 0.775p |
| Market Capitalisation: | £4.99m |
| VWAP: | 0.566667p |
| Shares in Issue: | 832.28m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
N4 Pharma Plc (N4P) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,636 | 0.60p | SI Trade |
16:35:02 - 27-Feb-26 |
| Sell* | 200 | 0.50p | SI Trade |
16:35:02 - 27-Feb-26 |
| Buy* | 200 | 0.60p | SI Trade |
16:35:02 - 27-Feb-26 |
| Sell* | 1,636 | 0.50p | SI Trade |
16:35:02 - 27-Feb-26 |
| Buy* | 67 | 0.60p | SI Trade |
16:35:02 - 27-Feb-26 |
| Sell* | 56,120 | 0.52p | Ordinary |
14:19:49 - 27-Feb-26 |
| Buy* | 128 | 0.59p | Ordinary |
14:08:59 - 27-Feb-26 |
| Buy* | 15,975 | 0.60p | Ordinary |
12:41:43 - 27-Feb-26 |
| Buy* | 3,235 | 0.60p | SI Trade |
11:20:37 - 27-Feb-26 |
| Buy* | 338,136 | 0.59p | Ordinary |
11:13:21 - 27-Feb-26 |
N4 Pharma Plc (N4P) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Feb 2026 7:00 am | RNS | Notice of GM and Proposed Change of Name |
| 24th Feb 2026 7:00 am | RNS | CEO Appointment & Name Change Thalia Therapeutics |
| 17th Dec 2025 7:00 am | RNS | Business and Operational Update |
| 25th Sep 2025 7:00 am | RNS | Interim Results |
| 23rd Sep 2025 7:00 am | RNS | Partnership with University of Strathclyde’s CMAC |
| 22nd Sep 2025 7:00 am | RNS | N4 Pharma’s Nuvec® Targets Lung Cancer Cells |
| 19th Sep 2025 7:00 am | RNS | Notice of Results, Analyst & Investor Presentation |
| 11th Sep 2025 7:00 am | RNS-R | Investor Event and Presentation |
| 30th Jul 2025 1:55 pm | RNS-R | Article on Nuvec®’s Potential in RNA Therapeutics |
| 14th Jul 2025 7:00 am | RNS-R | Investor Webinar |
